GPKOL 심포지엄초정연사 연번 Speaker Area Profile Hanjoo Kim (Director, Yuhan Corp) Korea - Yuhan Corp(2015-2019)/Director of R&D Strategy - Eisai(2014-2015)/Associate Director of Biostatistics - Cognizant Technology Solutions(2013-2014)/Senior Manager of BD - Novatis(2011-2013)/Sr.Principal Scientist of integrated information science - Forest Laboratory(2009-2011)/Sr.Biostatistician of Biostatistics - Wyeth pharm(2007-2009)/biostatistics fellow of Biostatistics - ITESM(2010)/Management and Leadership/Diploma - Intercontinental University(1997)/Marketing Strategy/Diploma - Intercontinental University(1996)/Administration/BA Alan Maceda (Latam Sales Manager, Pigmalion Pharma) Mexico - Pigmalion pharm(2018-)/manager of Exportation. - Business Consulting(2017-)/Founder - Stendhal(2012-2016)/Corporate Director - UCB(2008-2012)/Sr.Marketing Manager - Marketing and Sales Consultant(2005-2008)/Founder - Astrazeneca/Marketing manager(2000-2005)
- Universiada Adolfo Ibanez(2009)/MBA - University of Sao Paulo(1995)/Law/BA Fabio Deleuse (Managing Partner, Farmandala) Brazil - Farmandala(2017-)/Managing Partner - Techtrials(CRO)(2016-present)/Managing Partner of BD - Xian(Consultancy)(2015-present)/CEO - PharmaBind(Outsourcing)(2015-)/CEO - Lundbeck(2012-2015))/General Manager of Strategic Business - Astrazeneca(2007-2012)/Regional BGx Commercial Director and Business Unit Director Specialty Care - Organon Biosciences(2006-2007)/Marketing Director of Latin America and Middle East & Africa - Eli lilly Do Brasil Ltda(1994-2006)/Marketing Manager, Product Manager, Sales Manager David Kim (CEO, Curethereapeutics) Korea - Curethereapeutics(2014-)/CEO - JKD pharm(2012-2013)/director of BD - Daewoong pharm(2007-2009)/manager of C&D
- Zurich University(1983)/Business and Economics/BA Anthony Hoerning (Founder, Strategic Transactions Advisory AG) EU - Strategic Transactions Advisory(2015-)/Founder - Novatis/Head of global Alliance Management(2004-2014) - Novatis/Head of Mature of Products(2000-2004) - Novatis/Country CFO, Brazil(1998-2000) - Novatis/Head Investor Relations & Capital Markets(1993-1998) - JP Morgan/Vice President(1983-1993) - Moscow state Institute of International Relations(1991)/Russian-Japanese economic relations/ma Igor Dyachenko (CEO, Taishi Group) Russia - Taishi Group/CEO/(2002-present) - Siberian-Urals Aluminium Company(2000-2001)/Asia-Pacific region department, Head - Government of Japan(1996-2000)/Commission for TACIS, Expert - Hitotsubashi University(1994-1995)/Institue of Economic studies, Visiting professor - Metropol Commerce Bank(1992-1993)/External relations department, Head - MoFA USSR(1991-1992)/Asian department, Scientific fellow
- Purdue University(1992)/Synthetic Organic Chemistry/Ph.D - Jilin University(1985)/Chemistry/BS Qun Dang (Vice President, Qilu Pharmaceutical) China - Qilu Pharm(2018-)/Vice President, Global head of BD - Eli Lilly and company(2016-2018)/asia Head, External Innovation - Merck Research Laboratories(2009-2016)/Prinsipal Scientist, Senior Investigator, Dirertor of External Medical Chemistry - Metabasis Therapeutics(1992-2009)/Director of Medicinal Chemistry - Business Administration, Law/Master Fouad Begnhalem (CEO, Emcure Pharmaceutical) UAE - Emcure Pharmaceuticals Middle East & Africa(2012-)/CEO - GlaxoSmithKline Middle East & Africa(2000-2012)/Senior VP & Regional Director - Glaxo Wellcome Middle East & Africa(1992-1999)/Area Director - Pfizer Inc(1971-1992)/General Manager
- Kingston University(2007)/Pharmaceutical Sciences/MS - Mumbai University(2006)/Phrarmaceutial Sciences/BA Vishal Doshi (CEO, AUM biosciences) Singa pore - AUM Biosciences(2018-)/CEO - EPS International(2016-2018)/Head of Business Development, Asia - Icon Clinical Research(2015-2016)/Director of BD and Clinical Research - Quintiles East Asia Pte Ltd(2010-2015)/Business Development Manager - PharmaNet Ltd(2008-2010)/Business Development Associate - Columbia University(1985)/ MBA - Dartmouth College(1980)/ B.A. 10 Paula Ness Speers (Co-Founder and Managing Director, Health Advances) USA - Health Advances( 현재 )/Co-Founder and Managing Director - Bain & Company(1984-1992)/R&D Practice Manager and Head - Daewoo Shipyard, South Korea(1982-1983)/Atlantic Richfield Project/Associate Contracts Administrator - Samsung Shipbuilding Corporation, South Korea(1981-1982)/International Marketing Department/Translation and English Teacher - US Peace Corps(1980-1981)/Tuberculosis Control Worker
해외제약전문가비즈니스미팅신청 Experts Area Fields Profile - 중동지역 (GCC) 의약품 해외수출전략및시장개척 - 기술사업화및제품 - 온코파마중동아시아디렉터 (6 년 ) 11 UAE 공동개발과제휴관리 - Al Razi Pharmacy Co. & IBN * 의약품 ( 제네릭, 바이오 Khaldoon Drug Store(6 년 ) Kemal Hatip 케말하팁 포함 ), 바이오시밀러, 진단및의료기기 - 노바티스 Pharma Service(7 년 ) - Ciba Geigy Ltd(17년 ) - JFDA( 요르단식품약품관리안전처 ) GMP 감독 (5 년 ) - 약국장 (Al-Hussaain 교육병원 )(1 년 ) - 약사 (Al-Hussaain 교육병원 - MOH)(1 년 ) - 영업감독 ( 동부지역 ) 하얏트제약 12 요르단 - 요르단및중동 GMP - 제품등록및인허가 ( 사우디아라비아 ) (1년) - 진팜시니어의학대표 Mahmoud Alqawasmeh 마하모드알카와스마 ( 암만- 요르단수도지역 ) (1년) - 의학산업대표 (UAE 지역 )(2년) - 의학대표 (UAE 시장 - 약학산업 )(HIKMA 그룹 )(2년) - 요르단시장의학대표 (HIKMA 그룹 )(2 년 ) - 지아드약학약사대표 ( 자르카 - 요르단 )(1 년 )
13 Feng Tao 펑타오 중국 - 분야별중국시장분석 - 중국진출전략수립 - 최신중국시장흐름및정책보제공 - 제품선택 - 중국노바티스 Oncology Marketing Director(3년 ) - 시안-얀센 Senior Manager(2년 ) - 알러간인포메이션컨설팅 National Sales Manager(1년 ) - 시안-얀센 Region Manager(2년 ) - 브리스톨마이어스스큅 North Region Manager(7 년 ) - Beijing Lewei Biological & Technology. Co. Ltd. Senior Consultant(5 년 ) - 상하이존슨앤존슨제약 Medical & Regulatory Affairs 14 중국 - 중국인허가절차및법규 - 인허가전략 - 의약품전략적관리 Director(2년 ) - 와이어스제약 Regulatory Affairs Associate Director & Director(4년 ) Sun Xuemei 쑨쉐메이 - 시안-얀센제약 Regulatory Affairs Manager(4년 ) - 이외중국현지제약기업의 Sales Superviosr, Developing Manager, Division of Development, Pharmaceutical Science Centre Director 등역임